Detalhe da pesquisa
1.
I Didn't Want the Psychotic Thing to Get Out to Anyone at All: Adolescents with Early Onset Psychosis Managing Stigma.
Cult Med Psychiatry
; 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38869653
2.
Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years.
Psychol Med
; 51(9): 1570-1580, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156323
3.
CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.
J Clin Psychopharmacol
; 41(6): 667-672, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735099
4.
Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.
Child Adolesc Ment Health
; 25(2): 79-94, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32307841
5.
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
BMC Psychiatry
; 14: 199, 2014 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015535
6.
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.
J Am Acad Child Adolesc Psychiatry
; 58(11): 1062-1078, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30858012
7.
Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.
Psychopharmacology (Berl)
; 235(3): 681-693, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29185022
8.
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Lancet Psychiatry
; 4(8): 605-618, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599949